DuPont de Nemours, Inc. $DD Stock: Sumitomo Mitsui Trust Group Inc. Increases Holdings

Sumitomo Mitsui Trust Group Inc. lifted its position in DuPont de Nemours, Inc. (NYSE:DD) by 1.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 282,096 shares of the basic materials company’s stock after acquiring an additional 5,015 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 0.21% of DuPont de Nemours worth $36,641,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of DuPont de Nemours in the 3rd quarter valued at $4,565,000. Vise Technologies Inc. grew its stake in shares of DuPont de Nemours by 134.4% in the third quarter. Vise Technologies Inc. now owns 7,221 shares of the basic materials company’s stock worth $938,000 after acquiring an additional 4,140 shares during the last quarter. Americana Partners LLC increased its holdings in shares of DuPont de Nemours by 0.4% during the 3rd quarter. Americana Partners LLC now owns 24,855 shares of the basic materials company’s stock worth $3,228,000 after purchasing an additional 111 shares during the period. Lebenthal Global Advisors LLC grew its holdings in shares of DuPont de Nemours by 6.6% during the 3rd quarter. Lebenthal Global Advisors LLC now owns 4,368 shares of the basic materials company’s stock worth $567,000 after purchasing an additional 269 shares in the last quarter. Finally, Glenview Trust Co boosted its stake in DuPont de Nemours by 13.6% during the third quarter. Glenview Trust Co now owns 3,615 shares of the basic materials company’s stock worth $470,000 after buying an additional 434 shares in the last quarter. Institutional investors and hedge funds own 73.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on DD shares. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of DuPont de Nemours in a report on Friday, October 30th. Royal Bank Of Canada lowered their price target on shares of DuPont de Nemours from $176.00 to $160.00 and set an “outperform” rating for the company in a report on Thursday, October 15th. UBS Group increased their price objective on DuPont de Nemours from $172.00 to $182.00 and gave the company a “buy” rating in a research report on Wednesday. Zacks Research downgraded DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 17th. Finally, The Goldman Sachs Group cut their target price on shares of DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating on the stock in a research report on Wednesday, September 30th. Twelve analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $164.75.

DuPont de Nemours Price Performance

Shares of NYSE:DD opened at $151.15 on Thursday. DuPont de Nemours, Inc. has a 12 month low of $111.15 and a 12 month high of $157.98. The company has a current ratio of 2.36, a quick ratio of 1.82 and a debt-to-equity ratio of 0.23. The firm has a 50 day moving average of $132.93 and a 200-day moving average of $138.62. The stock has a market capitalization of $20.41 billion, a PE ratio of 67.78, a PEG ratio of 1.37 and a beta of 1.06.

DuPont de Nemours (NYSE:DD) last posted its earnings results on Tuesday, November 3rd. The basic materials company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.22. DuPont de Nemours had a net margin of 4.26% and a return on equity of 6.85%. The firm had revenue of $1.87 billion during the quarter, compared to analysts’ expectations of $1.84 billion. During the same quarter in the prior year, the business earned $1.09 earnings per share. The business’s revenue for the quarter was up 4.1% compared to the same quarter last year. On average, equities research analysts predict that DuPont de Nemours, Inc. will post 7.49 EPS for the current fiscal year.

DuPont de Nemours Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be given a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, November 30th. This represents a $2.40 annualized dividend and a dividend yield of 1.6%. DuPont de Nemours’s payout ratio is presently 533.33%.

DuPont de Nemours News Roundup

Here are the key news stories impacting DuPont de Nemours this week:

• Positive Sentiment: Analysts raised their targets and kept bullish ratings. UBS lifted its target to $182 and maintained a Buy rating; Citigroup raised its target to $176 with a Buy rating; and Barclays raised its target to $176 with an Overweight rating. UBS rating information Citigroup rating information Barclays rating information
• Positive Sentiment: Q3 results beat expectations and growth was broad-based. DuPont reported adjusted EPS of $2.09 versus the $1.87 consensus and revenue of about $1.9 billion, up 4% year over year; organic sales increased 5%. The company cited strong healthcare and aerospace demand. Reuters report on DuPont’s outlook
• Positive Sentiment: DuPont raised its 2026 outlook and plans further buybacks. After exceeding its third-quarter guidance, the company increased its full-year guidance and announced plans to repurchase $250 million of shares in the fourth quarter, supporting the investment case. DuPont third-quarter results
• Neutral Sentiment: A new peptide-purification product could offer a growth opportunity, but the supplied article listing does not provide enough detail to assess its likely revenue contribution. Article on DuPont’s peptide-purification product
• Negative Sentiment: DD has softened after its earnings-related surge. The coverage provided does not point to a specific adverse catalyst, so the pullback may reflect profit-taking rather than a deterioration in the reported business outlook.

DuPont de Nemours Profile

DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.

The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.